Evidence map›Paper›PMID 32178641›Full record

ArticleBMC ophthalmology2020

Nordic treatment practices survey and consensus for treatment of eyelid sebaceous carcinoma.

Tiina Leivo, Johanna Sarmela, Maria Enckell-Aaltonen, Eva Dafgård Kopp, Caroline Schmitt, Peter B Toft, Haraldur Sigurdsson, Marita Uusitalo

Open access · goldAbstract readMulticenter StudyConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC ophthalmology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Commentary: Cryotherapy and the sebaceous glands.Indian journal of ophthalmology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 5 countries.

Tiina LeivoDepartment of Ophthalmology, Helsinki University Hospital and University of Helsinki, PO Box 220, FI-00029 HUS, Helsinki, Finland. tiina.leivo@gmail.com.
Johanna SarmelaDepartment of Ophthalmology, Helsinki University Hospital and University of Helsinki, PO Box 220, FI-00029 HUS, Helsinki, Finland.
Maria Enckell-AaltonenDepartment of Ophthalmology, Helsinki University Hospital and University of Helsinki, PO Box 220, FI-00029 HUS, Helsinki, Finland.
Eva Dafgård KoppDepartment of Ophthalmology, S:t Erik's Eye Hospital, Karolinska Institutet, Stockholm, Sweden.
Caroline SchmittDepartment of Ophthalmology, Oslo University Hospital, Oslo, Norway.
Peter B ToftDepartment of Ophthalmology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Haraldur SigurdssonDepartment of Ophthalmology, Landspitali, University of Iceland, Reykjavik, Iceland.
Marita UusitaloDepartment of Ophthalmology, Helsinki University Hospital and University of Helsinki, PO Box 220, FI-00029 HUS, Helsinki, Finland.
Helsinki University Hospital · FIUniversity of Helsinki · FIKarolinska Institutet · SEOslo University Hospital · NORigshospitalet · DKUniversity of Iceland · IS

Funding

Evald ja Hilda Nissi Stiftelse (FI) not applicable
6 · The paper itself

Abstract

backgroundThe purpose was to describe the Nordic treatment practices and to reach a Nordic consensus for the treatment of sebaceous eyelid carcinoma.

methodsThe treatment practices data was collected by a questionnaire with 37 questions to the Nordic oculoplastic surgeons and analyzed. A PubMed MEDLINE database search was done to gather data on the published treatment practices and recommendations. A working group that consisted of in minimum one senior consultant from each leading Nordic University Eye Hospital was assigned. A structured interactive method was used to establish the consensus.

resultsTwenty-four doctors responded to the questionnaire. 23/24 (96%) of the respondents took a biopsy before surgery. Regional lymph node scanning was routinely done by 14/23 (61%) and a systemic screening of a metastatic disease by 13/23 (57%). 6/22 (27%) never took conjunctival mapping biopsies and 12/23 (52%) never screened for Muir- Torre. Respondents used Mohs surgery, frozen section or multi-stage excision with delayed closure, and 5-6 mm was the mostly preferred margin. Sentinel lymph node biopsy was a possible option for 9/22 (41%) and cryotherapy and Mitomycin C for 6/22 (27%) respondents. 50% of respondents considered radiation as a treatment option. 15/16 (94%) respondents always followed-up their patients, most for 5 years. Two thirds scanned regional lymph nodes during the follow-up. Consensus was reached for 18 statements representing three domains: preoperative work-up, treatment and follow-up.

conclusionTreatment practices differ in between the five Nordic countries which have similar public health care systems. In the article the authors present a Nordic consensus for the treatment of eyelid sebaceous carcinoma.

Indexed as

Adenocarcinoma, SebaceousAdultAgedCombined Modality TherapyEyelid NeoplasmsEyelidsFemaleFollow-Up StudiesHumansMaleMiddle AgedSebaceous Gland NeoplasmsSentinel Lymph Node BiopsySurveys and QuestionnairesConsensusEyelidNordicSebaceous carcinomaTreatment

Identifiers

PMID32178641
PMCPMC7074984
OpenAlexW3012536966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.